Search

everythinglearnresearchcommunity

for

Search:↓

Researchers found genetic mutations causing hypohidrotic ectodermal dysplasia in 88% of studied patients and identified new mutations and genetic variations affecting the disease.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Four patients with a type of rickets and hair loss had different mutations in their vitamin D receptor gene, causing it to not work properly.

The genes OVOL1 and OVOL2 are important for hair growth and may be involved in a type of skin tumor.

CEP135 may predict cancer outcomes, and targeting PLK1 could help treat certain sarcomas.

Two patients with skin lupus were mistakenly thought to have a different scalp condition but improved with lupus treatment.

HIV patients with lower CD4 T cell counts often have more skin problems.

Testosterone helps human pancreatic cells increase insulin release.

Most patients with telogen effluvium had low iron and vitamin D levels; iron supplements were commonly prescribed.

Activating the Nrf2 pathway reduces inflammation and cell activation in human hair follicles, suggesting a potential treatment for certain hair loss conditions.

wAMD patients have higher oxidative stress, suggesting antioxidant treatment may help.

BAFF-targeted therapies can reduce autoimmune disease activity, but more research is needed for precise treatments.

Severe hair loss links to metabolic issues in older men with psoriasis.

Low androgen levels can still cause female pattern hair loss.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

Pulse electric fields can control the release of growth factors and serotonin from platelet-rich plasma, offering a tailored approach to wound healing.

Two patients with the same genetic mutation had both blistering skin and easily pulled out hair.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

Celiac patients may have kidney function risks due to increased urea and creatinine and decreased magnesium, zinc, and vitamin C.

Lupus patients in Ghana face healthcare challenges, and the Oyemam Autoimmune Foundation is working to improve awareness and support.

PCOS patients have higher LDH and lower cortisol, dopamine, zinc, and vitamin D3, which may contribute to their symptoms and obesity.

Laryngectomy patients need special protection and care during COVID-19 to prevent infection.

Alopecia patients have less GPER-1, which might affect hair loss.

NF-κB is crucial for zebrafish heart repair, affecting heart cell growth and repair processes.

Minoxidil boosts hair growth by activating PGHS-1.

Wnt10b helps blood stem cells grow after injury.

MEL-A from soybean oil can boost fibroblast and papilla cells, potentially aiding hair growth.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.